Maxim Group Maintains Buy on Icecure Medical, Lowers Price Target to $1

Benzinga Newsdesk www.benzinga.com Negative 48.8%

Neg 48.8% Neu 0% Pos 0%

Maxim Group analyst Anthony Vendetti maintains Icecure Medical (NASDAQ:ICCM) with a Buy and lowers the price target from $3 to $1.